J K Joffe - JoVE Visualize

Showing results (1-10 of 16) with videos related to

Pageof 2

Sort By:

Clinical Oncology (Royal College of Radiologists (Great Britain))|February 9, 2000

Rectal carcinoma metastatic to the breastR L Lal, J K Joffe

Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995

Etoposide-related myocardial infarctionC L Airey, D J Dodwell, J K Joffe, et al.

Cancer Biotherapy & Radiopharmaceuticals|October 1, 1996

Cytokines in combination with chemotherapy for advanced renal carcinoma--the importance of patient selectionJ K Joffe, P M Patel, R E Banks, et al.

Experimental Hematology|April 1, 1995

G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM)J K Joffe, J B Bell, S Denham, et al.

British Journal of Cancer|May 20, 2004

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group studyA C Humphreys, J Dent, S Rodwell, et al.

British Journal of Cancer|January 1, 1997

A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinomaJ K Joffe, T J Perren, C Bradley, et al.

Experimental Hematology|February 1, 1992

Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitroB C Millar, J B Bell, J L Millar, et al.

British Journal of Haematology|December 1, 1990

Interleukin-6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogenicity of myeloma cells in vitroA M Borinaga, B C Millar, J B Bell, et al.

Hematological Oncology|November 1, 1990

Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisoloneJ B Bell, B C Millar, A Montes-Borinaga, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017

A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)J Shamash, S-J Sarker, R Huddart, et al.

Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:

Pageof 2

Clinical Oncology (Royal College of Radiologists (Great Britain))|February 9, 2000

Rectal carcinoma metastatic to the breastR L Lal, J K Joffe

Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995

Etoposide-related myocardial infarctionC L Airey, D J Dodwell, J K Joffe, et al.

Cancer Biotherapy & Radiopharmaceuticals|October 1, 1996

Cytokines in combination with chemotherapy for advanced renal carcinoma--the importance of patient selectionJ K Joffe, P M Patel, R E Banks, et al.

Experimental Hematology|April 1, 1995

G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM)J K Joffe, J B Bell, S Denham, et al.

British Journal of Cancer|May 20, 2004

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group studyA C Humphreys, J Dent, S Rodwell, et al.

British Journal of Cancer|January 1, 1997

A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinomaJ K Joffe, T J Perren, C Bradley, et al.

Experimental Hematology|February 1, 1992

Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitroB C Millar, J B Bell, J L Millar, et al.

British Journal of Haematology|December 1, 1990

Interleukin-6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogenicity of myeloma cells in vitroA M Borinaga, B C Millar, J B Bell, et al.

Hematological Oncology|November 1, 1990

Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisoloneJ B Bell, B C Millar, A Montes-Borinaga, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017

A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)J Shamash, S-J Sarker, R Huddart, et al.

Pageof 2